---
figid: PMC6891198__nihms-1540475-f0007
figtitle: ALK and RET inhibitors promote HLA class I antigen presentation and unmask
  new antigens within the tumor immunopeptidome
organisms:
- Homo sapiens
- Mus musculus
- Agriosomyces longus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6891198
filename: nihms-1540475-f0007.jpg
figlink: pmc/articles/PMC6891198/figure/F7/
number: F7
caption: MEK, ALK or RET positively regulate the output of the MAPK pathway, which
  in turn downregulates STAT1, which leads to reduced HLA. Inhibitors of these kinases,
  reverse the process.
papertitle: ALK and RET inhibitors promote HLA class I antigen presentation and unmask
  new antigens within the tumor immunopeptidome.
reftext: Claire Y. Oh, et al. Cancer Immunol Res. ;7(12):1984-1997.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9278222
figid_alias: PMC6891198__F7
figtype: Figure
redirect_from: /figures/PMC6891198__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6891198__nihms-1540475-f0007.html
  '@type': Dataset
  description: MEK, ALK or RET positively regulate the output of the MAPK pathway,
    which in turn downregulates STAT1, which leads to reduced HLA. Inhibitors of these
    kinases, reverse the process.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Alk
  - Ret
  - Mdk
  - Apk
  - Stat1
  - ALK
  - RET
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - STAT1
  - reticulated
  - reti
  - rets
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Dsor1
  - Mtk
  - Nplp1
---
